Anavex Life Sciences Corp (AVXL)

[sokol]

I think it is likely that Anavex is discussing the undisclosed rare disease clinical trial with another party, which could be a foundation other organization or entity. As Investor pointed out, Missling is a member of Rare Advocacy Group (RAM). Perhaps Missling is waiting to finalize the details of this trial. Or, maybe plans have been made, but the other party has requested confidentiality for now. The point is, there is an adequate reason, and it may be a favorable one to boot.

"RAM is focused on establishing a unified rare disease community amongst the already diverse real world rare disease landscape through the development of sustainable community enhancing programs, resources and opportunities dubbed RAM Collaborations." https://www.rareadvocacymovement.com

Anavex's pursuit of rare diseases is an essential factor that I believe investors are overlooking.

There are about 362 million people living with a rare disease worldwide - 2019 Statistic

5% of the global population has a rare disease. The current world population is 7.7 billion. - 2020 Statistic

Rare diseases may be eligible for numerous programs that may accelerate drug approval.

Anavex seems to be a front runner in treating CNS related rare diseases for which there is no cure.